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OBJECTIVES The objective of this study was to test the hypothesis that external-beam radiation induces a
chronic impairment of endothelium-dependent vasodilation.
BACKGROUND Radiation therapy is used commonly in the treatment of cancer and is associated with an
increased incidence of adverse vascular events related to the field of radiation, including stroke
and myocardial infarction. As endothelial injury is central to the pathogenesis of vascular
diseases, we hypothesized that radiotherapy induces arterial endothelial dysfunction.
METHODS Sixteen women with unilateral breast cancer who underwent standard external-beam
radiation therapy to the breast and axilla .3 years before enrollment and ten healthy women
were studied. Vascular ultrasonography was used to image both the artery exposed to radiation
and the contralateral artery. Flow-mediated, endothelium-dependent vasodilation and
endothelium-independent vasodilation to nitroglycerin of both axillary arteries were mea-
sured.
RESULTS Endothelium-dependent vasodilation was significantly impaired in the irradiated axillary
arteries compared with the contralateral, nonirradiated arteries (20.4 6 0.4% vs. 3.2 6 0.8%,
p , 0.001) and also compared with control subjects’ arteries (20.4 6 0.4% vs. 2.5 6 0.6%,
p , 0.001). In contrast, endothelium-independent vasodilation was greater in the arteries that
received radiation compared with the contralateral arteries (3.8 6 0.5% vs. 2.0 6 0.4%, p ,
0.05) and also compared with control arteries (3.8 6 0.5% vs. 2.5 6 0.4%, p , 0.05).
CONCLUSIONS External beam radiation therapy impairs endothelium-dependent vasodilation of conduit
arteries, implicating a decrease in the bioavailability of nitric oxide. These abnormalities may
contribute to the development of arterial occlusive disease and associated clinical events.
(J Am Coll Cardiol 2001;37:761–5) © 2001 by the American College of Cardiology
External-beam radiation therapy is commonly employed as
a primary and adjuvant therapeutic modality in patients with
neoplasms. Its mechanism of action is thought to involve
direct DNA damage, which causes cell death (1). Despite
improving technology and dose delivery, normal “bystander”
tissues, including the vasculature, are often affected. Indeed,
radiation therapy increases the incidence of arterial occlusive
disease years after therapy. The arterial lesions become
manifest in the region of previous radiation and can cause
clinical events in the cerebrovascular (2–5), coronary (6–8)
and peripheral circulations (9).
The mechanism whereby radiation therapy causes arterial
stenoses after radiation exposure is unclear, but important
consideration must be given to impairment of endothelial-
cell function. Decreased bioavailability of endothelium-
derived nitric oxide may contribute to vascular injury by
facilitating platelet aggregation, increasing the adherence of
leukocytes to the endothelial surface and by promoting
growth of vascular smooth cells (10). Abnormalities in
endothelium-dependent vasodilation and, by extension,
endothelium-derived nitric oxide have been demonstrated
to accompany risk factors for atherosclerosis (11–15) and
may also account for the predisposition to vascular disease in
arteries exposed to radiation. Abnormal endothelium-
dependent vasodilation has been demonstrated in animal
models and humans in vitro and in animals in vivo (16–19)
acutely after radiation exposure. There has been no inves-
tigation to determine if the effect of radiation therapy on the
endothelium persists chronically after radiation exposure,
thus providing a substrate for arterial disease.
Accordingly, the purpose of this study was to test the
hypothesis that endothelium-dependent vasodilation is im-
paired in vivo in human arteries exposed to radiation. We
used high-resolution ultrasound to measure endothelium-
dependent and endothelium-independent vasodilation in
the irradiated and contralateral nonirradiated axillary arter-
ies of women who underwent unilateral radiation therapy
for breast cancer.
METHODS
Patient selection and recruitment. Sixteen postmeno-
pausal women who had received unilateral adjunctive axil-
lary radiotherapy for breast cancer .3 years earlier were
eligible for enrollment. Subjects were recruited from the
clinic of one of the investigators (J.R.H.). Ten healthy,
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postmenopausal, age-matched women were also recruited
via advertisement and invited to participate in the study.
Exclusion criteria included diabetes mellitus, cigarette
smoking, total and low density lipoprotein (LDL) choles-
terol .75th percentile for age, untreated hypertension,
clinical manifestations of atherosclerosis, evidence of recur-
rent or second malignancy, severe lymphedema or other
major medical problem. All subjects underwent pre-
enrollment history and physical examination. Each subject
provided written, informed consent. This study was ap-
proved by the Human Research Committee of Brigham and
Women’s Hospital.
Vascular reactivity studies. Subjects were studied in a
quiet, temperature-controlled, dimly lit room after resting
supine for 5 min. High-resolution ultrasonography of the
axillary artery was performed using a Toshiba 270 SSA
ultrasound machine and 7.5 MHz linear array probe. The
axillary artery was imaged longitudinally just distal to the
axillary-subclavian junction, with the arm abducted 90°
from the body. The transducer position was adjusted to
obtain optimal images of the near and far walls of the
intima. Baseline images were simultaneously recorded on
super VHS videotape. The video output and electrocardio-
graphic signal of the ultrasound machine were connected to
a computer equipped with a Data Translation frame-
grabber videocard, (Dataviz, Trumbull, Connecticut). The
‘R’ wave on the electrocardiogram was used as a trigger to
acquire frames at end-diastole. After baseline image acqui-
sition, a mid-arm sphygmomanometric cuff was inflated to
suprasystolic pressure for 5 min. Upon cuff release, reactive
hyperemia causes flow to increase through the conduit
artery subserving the arm, in this case the axillary artery.
Flow-induced, endothelium-dependent vasodilation of the
axillary artery was determined via imaging at 1 min after cuff
deflation. Flow-mediated vasodilation at this time point is
largely nitric oxide mediated and endothelium dependent
and can be inhibited by administration of the nitric oxide
synthase antagonist, NG-monomethyl-L-arginine (20). Ten
minutes after cuff release, the axillary artery was imaged
again to re-establish baseline conditions. Then, to deter-
mine endothelium-independent vasodilation, subjects re-
ceived 0.4 mg of nitroglycerin, sublingually. The axillary
artery was imaged 3 min later. Axillary artery blood flow
velocity was determined via time-velocity integral measure-
ment and is reported as cm/s. At least 15 min after the
administration of nitroglycerin and after re-establishment of
pre-nitroglycerin heart rate and blood pressure (BP), the
procedure was repeated in the contralateral axillary artery.
Nitroglycerin was not administered if the systolic BP was
below 110 mm Hg.
Image analysis. Acquisition and analysis of the stored
images were performed using software designed for this
purpose (Information Integrity, Inc., Cambridge, Massa-
chusetts). At least four end-diastolic images for each con-
dition (baseline, reactive hyperemia, repeat baseline, nitro-
glycerin) were selected for analysis. Analysis was performed
by one investigator (J.A.B.) who was blinded to subject
name, date and presence or absence of radiation exposure.
The near and far walls were determined by derivative-based
edge detection after identification of the region of the
anterior and posterior walls by the investigator. The maxi-
mum diameter of the vessel was then determined. Arterial
diameter was measured from the vessel-lumen interface on
the posterior wall to the vessel-lumen interface of the
anterior wall.
Statistical analysis. Descriptive statistics are reported as
mean 6 standard deviation. Vasodilation is reported as
mean 6 standard error of the mean. Endothelium-
dependent and endothelium-independent vasodilation in
the axillary artery exposed to radiation therapy were first
compared using repeated measures analysis of variance.
Post-hoc, endothelium-dependent and endothelium-
independent vasodilation in the axillary artery exposed to
radiation therapy were compared with that of the contralat-
eral nonirradiated artery using a paired Student t test.
Comparisons of endothelium-dependent and independent
vasodilation of the irradiated arteries of patients to axillary
arteries of healthy control subjects were made using an
unpaired t test. Regression analysis was used to examine the
relationship between endothelium-dependent vasodilation
and selected subject characteristics. Statistical significance
was accepted at the p , 0.05 (95% confidence interval)
level.
RESULTS
Baseline characteristics. Twenty-six postmenopausal
women, including 16 subjects with prior radiation therapy
and 10 healthy control subjects, were enrolled. By group, the
participants were aged 58 6 10 and 58 6 4 years, had a
mean BP of 90 6 13 and 91 6 9 mm Hg, had a total
cholesterol of 203 6 21 and 212 6 20 mg/dl, and LDL of
121 6 17 and 116 6 22 mg/dl for the radiation-therapy
subjects and healthy control subjects, respectively. There
were no significant between group differences (all p 5 NS).
The average length of time between the last radiation
therapy and enrollment was 12 6 6 years. Nine patients had
had chemotherapy. One patient was taking tamoxifen. In
the radiation therapy group, three subjects had a history of
hypertension; two were taking beta-adrenergic blocking
agents, and one patient was taking an angiotensin-
converting enzyme inhibitor. They were asked to hold these
medications on the study day.
Abbreviations and Acronyms
BP 5 blood pressure
LDL 5 low density lipoprotein
MI 5 myocardial infarction
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Effect of radiation therapy on endothelium-dependent
vasodilation. The baseline diameters of the axillary arteries
in the subjects who received radiation therapy were 5.3 6
0.9 mm and 5.7 6 0.7 mm for the irradiated and nonirra-
diated contralateral arteries, respectively (p 5 0.06). Reac-
tive hyperemia augmented axillary artery flow velocity 240%
(from 9.8 cm/s to 23.8 cm/s) in the irradiated arteries and
260% (from 8.2 cm/s to 22.8 cm/s) in the nonirradiated,
contralateral arteries. The increase in blood flow velocity
was not significantly different in the irradiated and nonir-
radiated arteries (p 5 0.62). Flow-mediated, endothelium-
dependent vasodilation was lower in the arteries exposed to
radiation therapy than it was in the contralateral arteries and
in the arteries of the healthy, control subjects (p 5 0.001 by
analysis of variance) (Fig. 1). In a direct comparison
between the irradiated arteries and the contralateral arteries,
the irradiated arteries did not vasodilate, while the con-
tralateral arteries did (20.4 6 0.4% vs. 3.2 6 0.8%,
respectively; p , 0.001).
The baseline diameter of the axillary arteries in the
healthy, control subjects was 5.7 6 0.7 mm, and this was
not significantly different from the unexposed (i.e., nonir-
radiated) axillary arteries of the patients who received
radiation therapy (p 5 0.75). Flow-mediated vasodilation of
the axillary arteries of control subjects averaged 2.5 6 0.6%
and did not differ between arms. Flow-mediated vasodila-
tion was significantly greater in the axillary arteries of
control subjects than it was in the arteries of patients
exposed to radiation therapy (2.5 6 0.6% vs. 20.4 6 0.4%,
respectively; p , 0.001) (Fig. 1). Flow-mediated vasodila-
tion did not differ significantly between the nonirradiated
axillary arteries of the subjects who received radiation
therapy and the axillary arteries of control subjects (3.2 6
0.8% vs. 2.5 6 0.6%, p 5 0.51).
Effect of radiation therapy on exposed artery
endothelium-independent vasodilation. Seven of the pa-
tients who had previously received radiation therapy were
given nitroglycerin to determine endothelium-independent
vasodilation. Of those who did not receive nitroglycerin,
eight subjects had systolic BP below 110 mm Hg, and one
subject refused nitroglycerin. Endothelium-independent va-
sodilation was significantly greater in the irradiated arteries
compared with the nonirradiated arteries and the arteries of
the control subjects (p 5 0.048, by analysis of variance). In
a direct comparison, endothelium-independent vasodilation
was significantly greater in the irradiated arteries compared
with the nonirradiated arteries (3.8 6 0.5% vs. 2.0 6 0.4%,
p , 0.05) (Fig. 2). The arteries exposed to radiation therapy
also had a greater response to nitroglycerin than those of the
control subjects (3.8 6 0.5% vs. 2.5 6 0.4%, respectively;
p , 0.05).
Multivariate analysis. Subject age, total and LDL choles-
terol, BP, previous administration of chemotherapy and
length of time since radiotherapy administration did not
affect the flow-mediated and nitroglycerin-mediated vaso-
dilation of irradiated and nonirradiated arteries (all p 5 NS
by regression analysis). There was no significant interaction
between the vasodilation and any of the above factors (p 5
NS). There was no significant difference in flow-mediated
vasodilation or nitroglycerin-mediated vasodilation between
arms of the control subjects (p . 0.2 for both comparisons)
(Fig. 3).
DISCUSSION
The novel finding of these experiments is that external-
beam radiation therapy causes chronic impairment of
endothelium-dependent vasodilation in humans in vivo,
specific to arteries that received radiation. This observation
suggests that endothelial dysfunction may contribute to the
increased incidence of arterial occlusive disease that occurs
in patients who received radiation therapy.
Radiation modifies endothelial-cell function and reduces
its survival. Radiation causes the endothelial release of a
neutrophil chemoattractant, up-regulates endothelial ex-
pression of cellular adhesion and diapedesis molecules and
increases endothelial cell production of platelet derived
Figure 1. Effect of radiation therapy on flow-mediated vasodilation. The
individual and mean percent increase in axillary artery size 1 min after cuff
release compared with baseline is illustrated. Error bars represent standard
error. Flow-mediated vasodilation was significantly impaired in irradiated
arteries compared with nonirradiated arteries and arteries in control
subjects (p , 0.001).
Figure 2. Effect of radiation therapy on nitroglycerin-mediated vasodila-
tion. The individual and mean percent increase in axillary artery size after
nitroglycerin administration is shown. Error bars represent standard error.
Nitroglycerin-mediated vasodilation was significantly greater in irradiated
arteries compared with nonirradiated arteries and arteries in control
subjects (p , 0.05).
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growth factor (21–23). Irradiation of muscular (conduit)
arteries results in endothelial cell death, leaving the luminal
surface sparsely populated at six weeks. Irregular appearing
cells begin to repopulate the luminal surface 6 to 10 weeks
later (24).
Radiation and endothelium-derived nitric oxide. Studies
in animals and humans in vitro and animals in vivo suggest
that bioavailability of endothelium-derived nitric oxide is
diminished shortly after radiation exposure (16 –19).
Endothelium-dependent vasorelaxation to acetylcholine and
calcium ionophore in irradiated rabbit-ear arteries in vitro is
reduced, whereas nitroprusside-induced vasorelaxation is
preserved (18). In rats receiving prostate radiation, in vivo
erectile function and the number of nitric oxide synthase-
containing nerve fibers per corpus callosum is decreased
(19). In humans, endothelium-dependent vasodilation is
impaired in vitro, and tissue endothelial nitric oxide syn-
thase is decreased in carotid arteries four to six weeks after
neck irradiation (16). Our in vivo findings of impaired
endothelium-dependent vasodilation in irradiated arteries
extend these observations. We observed that endothelium-
dependent vasodilation was diminished in irradiated arteries
years beyond therapy.
There was a trend toward a smaller baseline diameter of
the irradiated axillary arteries compared with the contralat-
eral, nonirradiated axillary arteries and the axillary arteries of
the healthy, control subjects. The mechanisms whereby
radiation therapy may have reduced arterial diameter are not
known, but decreased nitric oxide is a plausible possibility.
Normal levels of nitric oxide are known to protect against
cellular apoptosis (25,26). The smaller baseline size may
reflect increased cellular apoptosis within the vessel as a
consequence of decreased nitric oxide bioavailability.
Endothelium-derived nitric oxide is also a potent vasodila-
tor and important in the regulation of arterial tone. Thus,
chronically diminished constitutive nitric oxide production
may result in a persistently smaller resting vessel lumen.
Radiation therapy and endothelium-independent vasodi-
lation. Endothelium-independent vasodilation was in-
creased in the irradiated axillary arteries compared with the
nonirradiated contralateral arteries and the arteries of con-
trol subjects. This finding may reflect the fact that smaller
arteries dilate proportionally more than larger arteries when
exposed to a vasodilator stimulus (27) or occur as a com-
pensatory response to any nitric oxide donor when endog-
enous nitric oxide is reduced (28).
Clinical significance. This study demonstrates that expo-
sure to radiation chronically impairs endothelial function.
Endothelial dysfunction is a form fruste of atherosclerosis
and may account, in part, for stenoses that occur in
irradiated arteries, such as the coronary, carotid and subcla-
vian/axillary circulations. Patients who receive mantle or
head and neck radiation therapy have an increased rate of
myocardial infarction (MI) (6–8) and stroke (2–5). In fact,
in women under age 60 who receive left chest irradiation,
the risk of MI is doubled (29). For younger patients who
survive their cancer, long-term morbidity and mortality is
increased by the life-saving radiotherapy. Our study pro-
vides evidence that endothelial dysfunction may be a target
for therapy to prevent these adverse outcomes.
Conclusions. The results of this study enable us to con-
clude that radiation therapy causes impairment of
endothelium-dependent vasodilation in exposed arteries.
The findings implicate reduced bioavailability of
endothelium-derived nitric oxide as an important mecha-
nism for the subsequent development of arterial occlusions
and vascular events in patients receiving radiation therapy.
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